Redhill Biopharma Ltd (NASDAQ:RDHL)

4.96
Delayed Data
As of Apr 23
 -0.05 / -1.00%
Today’s Change
4.30
Today|||52-Week Range
11.25
-3.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-10.6M-21.1M-29.5M-45.9M
 
 
 
 
 
Depreciation26.6K36.0K44.1K81.6K
 
 
 
 
 
Total Other Cash Flow1.8M656.7K516.6K-3.0M
 
 
 
 
 
Funds From Operations-8.7M-20.4M-28.9M-48.8M
 
 
 
 
 
Funds From/For Other Operating Expenses3.3M-2.6M-554.7K-3.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-12.1M-17.8M-28.3M-45.1M
 
 
 
 
 
 
InvestingIncrease In Investments-16.8M-29.5M-12.3M-35.2M
 
 
 
 
 
Decrease In Investments239.6K10.0M37.0M17.6M
 
 
 
 
 
Capital Expenditures-69.0K-14.0K-85.3K-147.0K
 
 
 
 
 
Net Cash Flow Investing-17.6M-21.2M24.5M-18.7M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale24.0M54.8M36.1M25.8M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing24.0M54.8M36.1M25.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-233.7K-149.9K39.1K369.6K
 
 
 
 
 
 
Net Change In Cash-5.6M15.8M32.3M-38.0M